Clinical Trials Logo

Clinical Trial Summary

The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03247140
Study type Interventional
Source Jeil Pharmaceutical Co., Ltd.
Contact
Status Completed
Phase Phase 1
Start date June 10, 2017
Completion date November 27, 2017

See also
  Status Clinical Trial Phase
Completed NCT03707899 - The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers Volunteers Phase 1